Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Fujimura

Showing results (191-200 of 283) with videos related to

Pageof 29
Sort By:
The Journal of Dermatology|July 22, 2016
Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patientTaku Fujimura, Yumi Kambayashi, Sadanori Furudate, et al.
Case Reports in Oncology|February 17, 2017
Recurrent Multiple Squamous Cell Carcinomas on the Scalp in a Patient with Juvenile DermatomyositisYota Sato, Taku Fujimura, Yumi Kambayashi, et al.
The Journal of Dermatology|January 24, 2019
Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapyTaku Fujimura, Yumi Kambayashi, Yota Sato, et al.
Anticancer Research|December 27, 2017
The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine OriginYumi Kambayashi, Taku Fujimura, Sadanori Furudate, et al.
Dermatologic Therapy|November 15, 2020
Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanomaRyo Amagai, Taku Fujimura, Yusuke Muto, et al.
Dermatologic Therapy|October 20, 2020
Erythema nodosum developed in a patient with advanced cutaneous melanoma treated with dabrafenib plus trametinib combination therapyYusuke Muto, Taku Fujimura, Yumi Kambayashi, et al.
The Journal of Dermatology|October 7, 2017
Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumabTaku Fujimura, Yumi Kambayashi, Takanori Hidaka, et al.
Case Reports in Oncology|May 18, 2017
Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene MonotherapyKayo Tanita, Taku Fujimura, Yota Sato, et al.
Acta Dermato-Venereologica|April 17, 2012
CD163+ adult xanthogranuloma arising from Merkel cell carcinoma treated with local radiotherapyRyoko Shimada, Taku Fujimura, Yumi Kambayashi, et al.
Cancers|March 29, 2023
LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated MacrophagesKentaro Ohuchi, Tetsuya Ikawa, Ryo Amagai, et al.
Pageof 29

Showing results (191-200 of 283) with videos related to

Sort By:
Pageof 29
The Journal of Dermatology|July 22, 2016
Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patientTaku Fujimura, Yumi Kambayashi, Sadanori Furudate, et al.
Case Reports in Oncology|February 17, 2017
Recurrent Multiple Squamous Cell Carcinomas on the Scalp in a Patient with Juvenile DermatomyositisYota Sato, Taku Fujimura, Yumi Kambayashi, et al.
The Journal of Dermatology|January 24, 2019
Successful treatment of unresectable recurrent programmed death ligand 1 moderately-expressing malignant melanoma of the nasal cavity with pembrolizumab monotherapyTaku Fujimura, Yumi Kambayashi, Yota Sato, et al.
Anticancer Research|December 27, 2017
The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine OriginYumi Kambayashi, Taku Fujimura, Sadanori Furudate, et al.
Dermatologic Therapy|November 15, 2020
Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanomaRyo Amagai, Taku Fujimura, Yusuke Muto, et al.
Dermatologic Therapy|October 20, 2020
Erythema nodosum developed in a patient with advanced cutaneous melanoma treated with dabrafenib plus trametinib combination therapyYusuke Muto, Taku Fujimura, Yumi Kambayashi, et al.
The Journal of Dermatology|October 7, 2017
Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumabTaku Fujimura, Yumi Kambayashi, Takanori Hidaka, et al.
Case Reports in Oncology|May 18, 2017
Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene MonotherapyKayo Tanita, Taku Fujimura, Yota Sato, et al.
Acta Dermato-Venereologica|April 17, 2012
CD163+ adult xanthogranuloma arising from Merkel cell carcinoma treated with local radiotherapyRyoko Shimada, Taku Fujimura, Yumi Kambayashi, et al.
Cancers|March 29, 2023
LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated MacrophagesKentaro Ohuchi, Tetsuya Ikawa, Ryo Amagai, et al.
Pageof 29